Psych Capital is floating on Aquis so that it can take advantage of the opportunities in the fast-growing psychedelic medicines sector. There is increasing interest in treatments using psychedelics and thereby investment in this area. More than $2bn has been invested in psychedelic companies and there are 47 quoted companies around the world in the sector.
However, Psych Capital is focused on early-stage companies that it can help to grow by providing marketing services and data.
The inve...
You are unauthorized to view this page.